Skip to main content
SpringerLink
Log in

Epidemiologie des Nierenzellkarzinoms in Deutschland 2019

Epidemiology of renal cell carcinoma in Germany in 2019

  • Epidemiologie
  • Published:
Die Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S et al (2022) European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 82(4):399–410

    Article  PubMed  Google Scholar 

  2. Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75(1):74–84

    Article  PubMed  Google Scholar 

  3. Editorial Board WHO Classification of Tumours (2022) Urinary and Male Genital Tumours, 5. Aufl. Bd. 8. International Agency for Research on Cancer, Lyon (France)

    Google Scholar 

  4. Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2(3):269–279

    Article  CAS  PubMed  Google Scholar 

  5. Brenner H, Gefeller O, Hakulinen T (2004) Period analysis for “up-to-date” cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer Oxf Engl 1990 40(3):326–335

    CAS  Google Scholar 

  6. Corazziari I, Quinn M, Capocaccia R (2004) Standard cancer patient population for age standardising survival ratios. Eur J Cancer Oxf Engl 1990 40(15):2307–2316

    Google Scholar 

  7. Holleczek B, Gondos A, Brenner H (2009) periodR—an R package to calculate long-term cancer survival estimates using period analysis. Methods Inf Med 48(2):123–128

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Landeskrebsregister NRW gGmbH, Gesundheitscampus 10, 44801, Bochum, Deutschland

    Lennart Möller, Andreas Stang & Hiltraud Kajüter

  2. Institut für Medizinische Informatik, Biometrie und Epidemiologie (IMIBE), Universitätsklinikum Essen, Essen, Deutschland

    Andreas Stang

Authors
  1. Lennart Möller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Stang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiltraud Kajüter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiltraud Kajüter.

Ethics declarations

Interessenkonflikt

L. Möller, A. Stang und H. Kajüter geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Möller, L., Stang, A. & Kajüter, H. Epidemiologie des Nierenzellkarzinoms in Deutschland 2019. Onkologie 29, 565–570 (2023). https://doi.org/10.1007/s00761-023-01362-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-023-01362-5

Search

Navigation